BD9660531
1-Methyl-4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)piperazine , 97% , 918524-63-7
CAS NO.:918524-63-7
Empirical Formula: C16H26BN3O2
Molecular Weight: 303.21
MDL number: MFCD07437995
| Pack Size | Price | Stock | Quantity |
| 100mg | RMB40.80 | In Stock |
|
| 250mg | RMB90.40 | In Stock |
|
| 1g | RMB139.20 | In Stock |
|
| 5g | RMB396.00 | In Stock |
|
| 25g | RMB1952.80 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 125 °C |
| Boiling point: | 435.2±45.0 °C(Predicted) |
| Density | 1.10±0.1 g/cm3(Predicted) |
| storage temp. | under inert gas (nitrogen or Argon) at 2-8°C |
| pka | 8.41±0.31(Predicted) |
| form | solid |
| color | white |
| InChI | InChI=1S/C16H26BN3O2/c1-15(2)16(3,4)22-17(21-15)13-6-7-14(18-12-13)20-10-8-19(5)9-11-20/h6-7,12H,8-11H2,1-5H3 |
| InChIKey | KVQXFNGVIIPCSX-UHFFFAOYSA-N |
| SMILES | N1(C)CCN(C2=NC=C(B3OC(C)(C)C(C)(C)O3)C=C2)CC1 |
Description and Uses
1-Methyl-4-[5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)pyridin-2-yl]piperazine is used to prepare yrazolopyridine and indazoles as histone lysine methyltransferase EZH2 inhibitors. It is also used to synthesize tetrahydropyrido pyrazines as anaplastic lymphoma kinase inhibitors.
Safety
| Symbol(GHS) | ![]() GHS07 |
| Signal word | Warning |
| Hazard statements | H315-H319-H335 |
| Precautionary statements | P261-P280-P305+P351+P338-P304+P340-P405-P501A |
| Hazard Codes | C |
| Risk Statements | 22-34 |
| Safety Statements | 22-26-36/37/39-45 |
| RIDADR | UN2811 |
| TSCA | No |
| HazardClass | 6.1 |
| HS Code | 2933998090 |
| Limited Quantities | 5.0 L (1.3 gallons) (liquid) or 5.0 kg (11 lbs) (solid) |
| Excepted Quantities | Max Inner Pack (30g or 30ml) and Max Outer Pack (1Kg or 1L) |







